Search research articles
Contact Us
Filters
Showing results (1-10 of 127) with videos related to
Page
of 13
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1989
Racemates or enantiomers: regulatory approaches
D J Birkett
Australian Family Physician
|
March 1, 1980
The practical application of drug assays in general practice
D J Birkett
British Journal of Clinical Pharmacology
|
October 1, 1995
Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee
D J Birkett, P McManus
Biochimica Et Biophysica Acta
|
December 20, 1982
The effects of N-B transition of human serum albumin on the specific drug-binding sites
S Wanwimolruk, D J Birkett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 6, 1976
The interactions between iophenoxic acid, iopanoic acid, bilirubin and human serum albumin as studied by fluorescence and Sephadex gel filtration
D J Birkett, J Kapitulnik
British Journal of Clinical Pharmacology
|
July 15, 1998
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
J O Miners, D J Birkett
General Pharmacology
|
March 1, 1996
The use of caffeine as a metabolic probe for human drug metabolizing enzymes
J O Miners, D J Birkett
British Journal of Clinical Pharmacology
|
April 1, 1991
Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events
D J Birkett, J O Miners
Clinical Pharmacology and Therapeutics
|
October 1, 1981
Cigarette smoking and theophylline clearance and metabolism
J J Grygiel, D J Birkett
Clinical Pharmacology and Therapeutics
|
October 1, 1980
Effect of age on patterns of theophylline metabolism
J J Grygiel, D J Birkett
Page
of 13
Search research articles
Search
Showing results (1-10 of 127) with videos related to
Sort By:
Page
of 13
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1989
Racemates or enantiomers: regulatory approaches
D J Birkett
Australian Family Physician
|
March 1, 1980
The practical application of drug assays in general practice
D J Birkett
British Journal of Clinical Pharmacology
|
October 1, 1995
Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee
D J Birkett, P McManus
Biochimica Et Biophysica Acta
|
December 20, 1982
The effects of N-B transition of human serum albumin on the specific drug-binding sites
S Wanwimolruk, D J Birkett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 6, 1976
The interactions between iophenoxic acid, iopanoic acid, bilirubin and human serum albumin as studied by fluorescence and Sephadex gel filtration
D J Birkett, J Kapitulnik
British Journal of Clinical Pharmacology
|
July 15, 1998
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
J O Miners, D J Birkett
General Pharmacology
|
March 1, 1996
The use of caffeine as a metabolic probe for human drug metabolizing enzymes
J O Miners, D J Birkett
British Journal of Clinical Pharmacology
|
April 1, 1991
Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events
D J Birkett, J O Miners
Clinical Pharmacology and Therapeutics
|
October 1, 1981
Cigarette smoking and theophylline clearance and metabolism
J J Grygiel, D J Birkett
Clinical Pharmacology and Therapeutics
|
October 1, 1980
Effect of age on patterns of theophylline metabolism
J J Grygiel, D J Birkett
Page
of 13